COVID-19 Antibody Responses in Cystic Fibrosis: CAR-CF - CAR-CF

Medical University of Innsbruck, University Clinic for Pediatrics III0 个研究点目标入组 5,000 人开始时间: 2021年7月27日最近更新: 2022年5月16日

试验速览

暂无简介。

•Consenting people with CF (pwCF) of any age, genotype, transplant status and disease severity will be eligible to participate in the study. The study population is expected to be representative of the general CF population.
•Are the trial subjects under 18? yes
•Number of subjects for this age range: 2450
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 2525
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 25

•There are no specific exclusion criteria other than refusal to give informed consent, or contraindication to venipuncture.

发起方

Medical University of Innsbruck, University Clinic for Pediatrics III